UNH UnitedHealth Group Incorporated

$428.79▲ +2.67% Healthcare Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$389.40B
P/E Ratio
32.3
Div Yield
2.22%
52W Range
234.60 - 461.62
% vs 50 MA
4.35%
% vs 200 MA
23.33%
RSI-14
54.4
MACD Histogram
-1.7000
Beta (1Y vs SPY)
0.49
Gross Rev
$449.71B
Gross Profit
$84.55B
EBITDA
$21.46B
COGS
$365.16B
Operating Exp
$63.09B
Operating Income
EBIT
Pretax Income
Net Income
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
AI Analysis
Generated May 27, 12:08 AM
Company Overview

UnitedHealth Group Incorporated is a diversified healthcare company operating through two primary segments: UnitedHealthcare, which provides health benefit plans, and Optum, which offers health services, technology, and data analytics. This integrated approach allows UNH to leverage its vast scale and data capabilities across the entire healthcare ecosystem, establishing it as a dominant player in both health insurance and healthcare services.

Bull Case
  • UNH benefits from a highly diversified business model, with its Optum segment (healthcare services, technology) offering significant growth potential and mitigating risks associated with the traditional health insurance business.
  • The company is well-positioned to capitalize on long-term demographic trends, including an aging global population and increasing demand for healthcare services, driving sustained growth in both its benefits and services divisions.
  • As one of the largest healthcare companies globally, UNH enjoys substantial economies of scale, strong negotiating power, and an extensive network, creating significant competitive moats and barriers to entry.
  • UNH's Optum segment is a leader in healthcare innovation, leveraging data analytics, technology, and value-based care models, which positions the company for future efficiency gains, improved patient outcomes, and market share expansion.
Bear Case
  • The healthcare sector is highly susceptible to regulatory and political risks; potential changes in government healthcare policy, such as 'Medicare for All' proposals or stricter drug pricing regulations, could significantly impact UNH's profitability.
  • With a P/E ratio of 28.4, UNH appears to have a relatively high valuation, suggesting that future growth expectations may already be priced in and making the stock potentially vulnerable to multiple compression if growth slows or market sentiment shifts.
  • Despite its dominant position, UNH faces intense competition from other large insurers, emerging healthcare technology companies, and provider groups, which could lead to pricing pressures and margin erosion.
  • As a large, complex organization, UNH is exposed to operational risks, including potential data breaches, complex litigation related to claims or antitrust, and challenges in integrating acquisitions, all of which could incur substantial costs.
Recent Performance

UNH is currently trading at $376.86, experiencing a notable daily decline of 3.0%. Despite this recent pullback, the stock remains in a strong uptrend, trading significantly above both its 50-day (+14.1%) and 200-day (+16.9%) moving averages. While it is 6.8% below its 52-week high, the RSI-14 of 59.1 indicates a neutral-to-bullish momentum, suggesting the stock is not overbought and may have room for recovery after this short-term correction.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙